Bempedoic Acid: A New Drug for an Old Problem.

Dat NguyenNathan DuElisabeth M SulaicaMatthew A Wanat

Published in: The Annals of pharmacotherapy (2020)

The recent FDA approval of bempedoic acid offers an additional option for lowering LDL-C levels in patients with atherosclerotic cardiovascular disease or heterozygous familial hyperlipidemia. Additional data regarding effect on long-term cardiovascular outcomes with bempedoic acid are currently being studied.

Keyphrases

cardiovascular disease
type diabetes
emergency department
electronic health record
high fat diet
metabolic syndrome
machine learning
adipose tissue
cardiovascular events